欢迎来到CSNpharm!产品仅用于科研!

400-920-2911 sales@csnpharm.cn

0

您的位置 : 首页  /  Protein Tyrosine Kinase/RTK  /  ALK  /  (R)-6-Amino-5-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)-N-(4-(4-methylpiperazine-1-carbonyl)phenyl)pyridazine-3-carboxamide

CAS No.: 1365267-27-1

(R)-6-Amino-5-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)-N-(4-(4-methylpiperazine-1-carbonyl)phenyl)pyridazine-3-carboxamide Catalog No. CSN18668

Synonyms: Ensartinib;Ensartinib-analog;X 396-analog

Ensartinib is a potent inhibitor ofALK, which is used to treat non-small-cell lung cancer.

规格 价格 促销价格 库存 数量
纯度 & 质量文件 批次:

靶点选择性

生物活性

  • 描述
  • 临床研究
  • NCT号适应症或疾病临床期招募状态预计完成时间地点
    NCT03574402Carcinoma, Non-Small-Cell LungPhase 2Not yet recruitingDecember 30, 2024-
    NCT03155620Advanced Malignant Solid Neopl... more >>asm Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma Ann Arbor Stage IV Childhood Non-Hodgkin Lymphoma Childhood Langerhans Cell Histiocytosis Histiocytic Sarcoma Juvenile Xanthogranuloma Malignant Glioma Recurrent Central Nervous System Neoplasm Recurrent Childhood Ependymoma Recurrent Childhood Malignant Germ Cell Tumor Recurrent Childhood Medulloblastoma Recurrent Childhood Non-Hodgkin Lymphoma Recurrent Childhood Rhabdomyosarcoma Recurrent Childhood Soft Tissue Sarcoma Recurrent Ewing Sarcoma Recurrent Glioma Recurrent Hepatoblastoma Recurrent Langerhans Cell Histiocytosis Recurrent Malignant Solid Neoplasm Recurrent Neuroblastoma Recurrent Osteosarcoma Recurrent Peripheral Primitive Neuroectodermal Tumor Recurrent Rhabdoid Tumor Refractory Central Nervous System Neoplasm Refractory Childhood Malignant Germ Cell Tumor Refractory Ewing Sarcoma Refractory Glioma Refractory Hepatoblastoma Refractory Langerhans Cell Histiocytosis Refractory Malignant Solid Neoplasm Refractory Medulloblastoma Refractory Neuroblastoma Refractory Non-Hodgkin Lymphoma Refractory Osteosarcoma Refractory Peripheral Primitive Neuroectodermal Tumor Refractory Rhabdoid Tumor Refractory Rhabdomyosarcoma Rhabdoid Tumor Stage III Osteosarcoma AJCC v7 Stage III Soft Tissue Sarcoma AJCC v7 Stage IV Osteosarcoma AJCC v7 Stage IV Soft Tissue Sarcoma AJCC v7 Stage IVA Osteosarcoma AJCC v7 Stage IVB Osteosarcoma AJCC v7 Wilms Tumor Collapse <<Phase 2RecruitingSeptember 30, 2027-
    NCT03215693Non-Small Cell Lung CancerPhase 2RecruitingDecember 2018China ... more >> Beijing Cancer Hospital Recruiting Beijing, China Contact: Jian Fang, MD    13701224460    fangjian5555@163.com    Principal Investigator: Jun Zhao, MD          Beijing Chest Hospital,Capital Medical University Recruiting Beijing, China Contact: Shucai Zhang, MD    13901297065    sczhang6304@163.com    Department of Medical Oncology, Cancer Institute/Hospital, Chinese Academy of Medical Sciences Recruiting Beijing, China Contact: Junling Li, MD    13801178891    drlijunling@vip.163.com    Peking Union College Hospital Recruiting Beijing, China Contact: Wei Zhong, MD    13810616395    zw_pumch@126.com Collapse <<
  • 更多
  • 参考文献

实验方案

技术信息

CAS号 1365267-27-1 储存条件
分子式 C25H25Cl2FN6O3 运输 蓝冰
分子量 547.41 别名 Ensartinib;Ensartinib-analog;X 396-analog

大规格询价

号为必填项

姓名: 邮箱: 手机号:
留言:
   提交
联系
我们